Endocrine Group, LLP

Albany, New York 12206

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Disease, Dyslipidemia, Type 2 Diabetes, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) — Completed